The E3 ubiquitin ligases RNF43 and ZNRF3 are key negative regulators of canonical WNT signaling, promoting turnover of the WNT receptors Frizzled and LRP5/6 at the plasma membrane. Although their mechanism of action is well established, how RNF43/ZNRF3 themselves are regulated remains unclear. Here, through proximity labeling proteomics, we identify WNK kinases as regulators of RNF43. Using gain- and loss-of-function approaches, we show that WNKs control RNF43 surface localization and thereby its ability to downregulate WNT receptors. Pharmacological inhibition of WNKs increases RNF43 membrane abundance and enhances WNT suppression—an effect abolished in RNF43/ZNRF3 double-knockout cells and organoids. Mechanistically, WNK inhibition alters RNF43 trafficking and ubiquitination, revealing a role for WNKs in regulating its plasma membrane distribution. These findings uncover a new regulatory axis linking the pro-WNT activity of WNKs to RNF43/ZNRF3-mediated feedback inhibition, and identify WNK inhibition as a potential therapeutic strategy to restore WNT pathway control in cancers harboring RSPO fusions or RNF43 mutations.

WNK kinases control RNF43 plasma membrane levels to fine-tune WNT signaling

Gabriele Colozza
2026-01-01

Abstract

The E3 ubiquitin ligases RNF43 and ZNRF3 are key negative regulators of canonical WNT signaling, promoting turnover of the WNT receptors Frizzled and LRP5/6 at the plasma membrane. Although their mechanism of action is well established, how RNF43/ZNRF3 themselves are regulated remains unclear. Here, through proximity labeling proteomics, we identify WNK kinases as regulators of RNF43. Using gain- and loss-of-function approaches, we show that WNKs control RNF43 surface localization and thereby its ability to downregulate WNT receptors. Pharmacological inhibition of WNKs increases RNF43 membrane abundance and enhances WNT suppression—an effect abolished in RNF43/ZNRF3 double-knockout cells and organoids. Mechanistically, WNK inhibition alters RNF43 trafficking and ubiquitination, revealing a role for WNKs in regulating its plasma membrane distribution. These findings uncover a new regulatory axis linking the pro-WNT activity of WNKs to RNF43/ZNRF3-mediated feedback inhibition, and identify WNK inhibition as a potential therapeutic strategy to restore WNT pathway control in cancers harboring RSPO fusions or RNF43 mutations.
2026
Woo Seo, Dong; Sosa, Eric; Jordens, Ingrid; Ha, Jeongmin; Sam Wu, Szu-Hsien; Tavernini, Katherina; Català-Bordes, Andrea; Farnhammer, Fiona; Urbán, No...espandi
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11568/1378308
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? 0
social impact